JPRN-UMIN000031161
Completed
未知
A exploratory study to evaluate the efficacy of the narrow band UVB therapy by Area selection type ultraviolet radiation treatment device in subjects with papuloerythroderma of Ofuji - the narrow band UVB therapy by Area selection type ultraviolet radiation treatment device in subjects with papuloerythroderma of Ofuji
Kobe University Graduate School of Medicine0 sites10 target enrollmentApril 1, 2018
Conditionspapuloerythroderma of Ofuji
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- papuloerythroderma of Ofuji
- Sponsor
- Kobe University Graduate School of Medicine
- Enrollment
- 10
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\.Patients with malignant tumor complications 2\.Patient with complication of skin malignancy or previous medical history 3\.Patients with high cancer risk 4\.Patients diagnosed with eczema secondary erythroderma (senile erythroderma), chronic prurigo, atopic dermatitis, drug eruption, lichen planus, eosinophilia syndrome, cutaneous amyloidosis, cutaneous lymphoma , leukemia 5\.Patients undergoing Cyclosporine oral administration, etretinate orally,immunosuppressive therapy treatment 6\. patients undergoing oral corticosteroid treatment with 21 mg or more per day in terms of prednisolone 7\.Patients whose usage, dose of oral treatment, topical treatment has been changed within 2 weeks 8\.Patients taking drugs that cause photosensitivity, patients with outstanding photosensitivity 9\.Patients who have received UVB ultraviolet radiation therapy within 3 months 10\.Patients who participated in other clinical trials within 4 months 11\.patients judged inappropriate
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
An exploratory study to evaluate the efficacy of novel enteral nutrition VVT-01 for nasal tube feeding patientsnasal tube feeding patientsJPRN-UMIN000036569Michinoo hospital20
Completed
Not Applicable
An exploratory study to evaluate the efficacy of the single ingestion of milk protein hydrolysate on cerebral activity.JPRN-UMIN000025347Morinaga Milk Industry Co., LTD.36
Active, not recruiting
Phase 1
The exploratory study of EFE in COVID-19 patientsCOVID-19JPRN-jRCT2031210063Odaguchi Hiroshi156
Active, not recruiting
Phase 1
Reseach study that will evaluate the efficacy and safety of Bilastine in reducing itching in patients with chronic spontaneous urticaria and other skin diseases.Chronic spontaneous urticaria and the following skin disorders:1 - Eczema/dermatitis (acute eczema, chronic eczema, contact dermatitis, atopic dermatitis, nummular eczema, autosensitisation dermatitis, dyshidrotic eczema, asteatotic eczema, lichen simplex chronicus).2 - Prurigo (acute prurigo, subacute prurigo, chronic prurigo).3 - Cutaneous pruritus (systemic cutaneous pruritus, local cutaneous pruritus).MedDRA version: 19.0Level: HLTClassification code 10012435Term: Dermatitis and eczemaSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersMedDRA version: 19.0Level: PTClassification code 10037083Term: PrurigoSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersMedDRA version: 19.0Level: PTClassification code 10052568Term: Urticaria chronicSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersTherapeutic area: Diseases [C] - Skin and Connective Tissue Diseases [C17]EUCTR2016-001505-17-ESFAES FARMA, S.A.115
Active, not recruiting
Phase 1
Reseach study that will evaluate the efficacy and safety of Bilastine in reducing itching in patients with chronic spontaneous urticaria and other skin diseases.EUCTR2016-001505-17-HUFAES FARMA, S.A.115